Citation: C. Gabay et Wp. Arend, TREATMENT OF RHEUMATOID-ARTHRITIS WITH IL-1 INHIBITORS, Perspectives in mathematical logic, 20(1-2), 1998, pp. 229-246
Authors:
MALYAK M
GUTHRIDGE JM
HANCE KR
DOWER SK
FREED JH
AREND WP
Citation: M. Malyak et al., CHARACTERIZATION OF A LOW-MOLECULAR-WEIGHT ISOFORM OF IL-1 RECEPTOR ANTAGONIST, The Journal of immunology (1950), 161(4), 1998, pp. 1997-2003
Authors:
MALYAK M
SMITH MF
ABEL AA
HANCE KR
AREND WP
Citation: M. Malyak et al., THE DIFFERENTIAL PRODUCTION OF 3 FORMS OF IL-1 RECEPTOR ANTAGONIST BYHUMAN NEUTROPHILS AND MONOCYTES, The Journal of immunology (1950), 161(4), 1998, pp. 2004-2010
Citation: C. Gabay et al., INTERLEUKIN (IL)-4 AND IL-13 DIFFERENTIALLY REGULATE PRODUCTION OF IL-1 RECEPTOR ANTAGONIST AND OF C-REACTIVE PROTEIN BY HUMAN HEPATOCYTES, Arthritis and rheumatism, 41(9), 1998, pp. 25-25
Authors:
GABAY C
WILLIAMS RO
BUTLER DM
PORTER B
FELDMANN M
AREND WP
Citation: C. Gabay et al., INTERLEUKIN-1 RECEPTOR ANTAGONIST ISOFORMS IN COLLAGEN-INDUCED ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 1084-1084
Authors:
JENKINS JK
DRONG RF
SHUCK ME
BIENKOWSKI MJ
SLIGHTOM JL
AREND WP
SMITH MF
Citation: Jk. Jenkins et al., INTRACELLULAR IL-1 RECEPTOR ANTAGONIST PROMOTER - CELL-TYPE-SPECIFIC AND INDUCIBLE REGULATORY REGIONS, The Journal of immunology, 158(2), 1997, pp. 748-755
Citation: C. Gabay et al., MOUSE IL-1 RECEPTOR ANTAGONIST ISOFORMS - COMPLEMENTARY-DNA CLONING AND PROTEIN EXPRESSION OF INTRACELLULAR ISOFORM AND TISSUE DISTRIBUTIONOF SECRETED AND INTRACELLULAR IL-1 RECEPTOR ANTAGONIST IN-VIVO, The Journal of immunology, 159(12), 1997, pp. 5905-5913
Citation: C. Gabay et al., INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IS AN ACUTE-PHASE PROTEIN, The Journal of clinical investigation, 99(12), 1997, pp. 2930-2940
Citation: Ba. Michel et al., CLINICAL-DIFFERENTIATION BETWEEN GIANT-CELL (TEMPORAL) ARTERITIS AND TAKAYASUS-ARTERITIS, Journal of rheumatology, 23(1), 1996, pp. 106-111
Authors:
MALYAK M
SMITH MF
HANCE KR
DOWER SK
AREND WP
Citation: M. Malyak et al., CHARACTERIZATION OF A NOVEL, 16 KD, INTRACELLULAR FORM OF IL-1 RECEPTOR ANTAGONIST (IL-1RA), Arthritis and rheumatism, 39(9), 1996, pp. 558-558
Citation: C. Gabay et al., INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) IS PRODUCED BY HEPATOCYTESAND REGULATED AS AN ACUTE-PHASE PROTEIN, Arthritis and rheumatism, 39(9), 1996, pp. 1171-1171
Authors:
GUTHRIDGE CJ
GUITIERREZHARTMAN A
AREND WP
EIDLEN D
SMITH MF
Citation: Cj. Guthridge et al., REGULATION OF IL-IRA GENE-EXPRESSION BY RAF KINASE, MEK KINASE, AND LIPOPOLYSACCHARIDE, The FASEB journal, 9(4), 1995, pp. 823-823
Authors:
SVENSON M
NEDERGAARD S
HEEGAARD PMH
WHISENAND TD
AREND WP
BENDTZEN K
Citation: M. Svenson et al., DIFFERENTIAL BINDING OF HUMAN INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST TO NATURAL AND RECOMBINANT SOLUBLE AND CELLULAR IL-1 TYPE-I RECEPTORS, European Journal of Immunology, 25(10), 1995, pp. 2842-2850
Citation: Wp. Arend et Jm. Dayer, INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 38(2), 1995, pp. 151-160
Citation: Jk. Jenkins et al., THE EFFECTS OF INTERLEUKIN-10 ON INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-1-BETA PRODUCTION IN HUMAN MONOCYTES AND NEUTROPHILS, Lymphokine and cytokine research, 13(1), 1994, pp. 47-54